ALAN KAYE

Allopathic & Osteopathic Physicians|Internal Medicine DALLAS, TX NPI 1558308643

General Payments — all program years on this page

$4,089.88

  • Category: General Payments
  • Program years: PY2018–2024
  • Record count: 252
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $503.64 across 21 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $503.6421

By paying entity

Latest program year (PY2024) · sorted by reported total.

By program year

Program yearAmountRecords
2018 $1,690.36102
2019 $1,510.04105
2020 $348.2422
2021 $11.601
2022 $26.001
2024 $503.6421

Records — PY2024 (21)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1082150437 Dynavax Technologies Corporation $21.55 08/13/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1097009490 Novo Nordisk Inc $18.56 10/29/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1101377486 E.R. Squibb & Sons, L.L.C. $26.67 07/02/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1101377516 E.R. Squibb & Sons, L.L.C. $13.59 11/05/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1111616233 Amgen Inc. $13.10 10/15/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1113905855 Paratek Pharmaceuticals, Inc. $15.87 09/03/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1114729381 Exact Sciences Corporation $14.35 11/12/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116557269 GlaxoSmithKline, LLC. $17.49 10/02/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1117293763 Amgen Inc. $14.21 06/18/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1117293765 Amgen Inc. $14.38 08/27/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1125122103 Abbott Laboratories $21.71 08/14/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1131125497 PFIZER INC. $19.00 11/05/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1131225730 PFIZER INC. $20.61 11/19/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1136008391 Lilly USA, LLC $18.05 04/10/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1136013830 Lilly USA, LLC $18.54 06/04/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1136014046 Lilly USA, LLC $17.23 02/06/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1139321786 Astellas Pharma US Inc $19.78 04/16/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1139361171 Astellas Pharma US Inc $17.78 06/25/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1139647140 SANOFI-AVENTIS U.S. LLC $15.20 11/26/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1141721348 Merck Sharp & Dohme LLC $20.68 10/08/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1148065992 Inspire Medical Systems, Inc. $145.29 06/25/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.